Log in
Enquire now
‌

US Patent 11753469 Methods of using bispecific CD33 and CD3 binding proteins

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11753469
Patent Inventor Names
Jeanmarie Dean Guenot
Luke Evnin
Lori Kunkel
Date of Patent
September 12, 2023
Patent Application Number
16989671
Date Filed
August 10, 2020
Patent Citations
‌
US Patent 7612181 Dual variable domain immunoglobulin and uses thereof
‌
US Patent 7820166 Potent T cell modulating molecules
‌
US Patent 8076459 Multispecfic deimmunized CD3-binders
‌
US Patent 8101722 Less immunogenic binding molecules
‌
US Patent 8236308 Composition comprising cross-species-specific antibodies and uses thereof
‌
US Patent 8258268 Dual variable domain immunoglobulin and uses thereof
‌
US Patent 8409577 Single chain multivalent binding proteins with effector function
‌
US Patent 8518403 Expression-enhanced polypeptides
...
Patent Primary Examiner
‌
Meera Natarajan

Described herein are binding proteins that specifically bind to human CD33, and in particular to bispecific binding proteins that specifically bind to human CD33 and human CD3. Also described herein are bispecific tandem diabodies that bind to CD33 and CD33, and their uses for immunotherapy of CD33

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11753469 Methods of using bispecific CD33 and CD3 binding proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.